Authors:
BETTENCOURT MC
BAUER JJ
SESTERHENN IA
CONNELLY RR
MOUL JW
Citation: Mc. Bettencourt et al., CD34 IMMUNOHISTOCHEMICAL ASSESSMENT OF ANGIOGENESIS AS A PROGNOSTIC MARKER FOR PROSTATE-CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY, The Journal of urology, 160(2), 1998, pp. 459-465
Authors:
BETTENCOURT MC
MORRIS ER
SPEVAK M
COSTABILE R
Citation: Mc. Bettencourt et al., THE EFFECT OF HUMAN CHORIONIC-GONADOTROPIN ON METHOTREXATE CONCENTRATION IN THE RAT TESTES, The Journal of urology, 158(4), 1997, pp. 1581-1584
Authors:
BAUER JJ
CONNELLY RR
SESTERHENN IA
BETTENCOURT MC
MCLEOD DG
SRIVASTAVA S
MOUL JW
Citation: Jj. Bauer et al., BIOSTATISTICAL MODELING USING TRADITIONAL VARIABLES AND GENETIC BIOMARKERS FOR PREDICTING THE RISK OF PROSTATE CARCINOMA RECURRENCE AFTER RADICAL PROSTATECTOMY, Cancer, 79(5), 1997, pp. 952-962
Authors:
MOUL JW
BETTENCOURT MC
SESTERHENN IA
MOSTOFI FK
MCLEOD DG
SRIVASTAVA S
BAUER JJ
Citation: Jw. Moul et al., PROTEIN EXPRESSION OF P53, BCL-2, AND KI-67 (MIB-1) AS PROGNOSTIC BIOMARKERS IN PATIENTS WITH SURGICALLY TREATED, CLINICALLY LOCALIZED PROSTATE-CANCER, Surgery, 120(2), 1996, pp. 159-167
Authors:
BETTENCOURT MC
BAUER JJ
SESTERHENN IA
MOSTOFI FK
MCLEOD DG
MOUL JW
Citation: Mc. Bettencourt et al., KI-67 EXPRESSION IS A PROGNOSTIC MARKER OF PROSTATE-CANCER RECURRENCEAFTER RADICAL PROSTATECTOMY, The Journal of urology, 156(3), 1996, pp. 1064-1068